Abstract:Objective To study programmed death-1 (PD-1) and T-cell immunoglobulin mucin3 (Tim-3) co-expression on peripheral blood mononuclear cells (PBMC) and hepatitis B virus (HBV)-specific CD8+ T cells in patients with chronic HBV infection and its correlation with liver inflammatory activities.Methods One hundred and sixty subjects with chronic HBV infection who visited the outpatient and inpatient Department of Infectious Diseases in the Third Affiliated Hospital of Sun Yatsen University were enrolled,including 63 cases of mild or moderate CHB (MCHB),31 of severe CHB (SCHB),55 of acute-on-chronic liver failure (ACLF) and 11 inactive HBsAg carriers.Twenty healthy subjects were enrolled as controls.Real-time quantitative polymerase chain reaction (qRT-PCR) was used to detect HBV DNA,enzyme-linked immunosorbent assay (ELISA) to measure HBV serological markers,and flow cytometry to detect human leukocyte antigen (HLA)-A2 and determine the expression of PD-1 and Tim-3 on PBMC and HBV-specific CD8+ T cells.Cell counts of Tim-3+,PD-1+,and Tim-3+/PD1+ PBMC and HBV-specific CD8+ T cells were compared among different groups,and their correlation with commonly used inflammatory activity indicators were studied.Analysis of variance and Kruskal-Wallis test were used for measurement data with gaussian distribution and skewed distribution,respectively.Spearman correlation analysis was used to assess the association between Tim-3/PD-1 expression and inflammatory activity indicators.Results The frequency of Tim-3+/PD-1+ PBMC was 0.25 ％ in ACLF group (P=0.0049),0.24 ％ in SCHB group (P-0.0025) and 0.13％ in MCHB group (P=0.0006),which were significantly higher than that in control group (0.03％),and the frequency of Tim-3 /PD-1-PBMC in the three groups were significantly lower than that in control group (P =0.0000),but the differences between HBsAg carriers (0.10％) and controls (0.03％) were not statistically significant (P=0.28).Among 160 subjects,78 were HLA-A2 positive.The frequency of Tim-3+/PD-1+ HBV-specific CD8+ T cells was 68.72％±17.21％ in ACLF group,and 59.66％± 19.25％ in SCHB group,which were significantly higher than that in HBsAg carrier group (33.93％ ± 10.80％,P=0.0000,P=0.0054).The frequency of Tim-3 /PD-1-HBV-specific CD8+ T cells in ACLF group was 2.80％,which was significantly lower than that in HBsAg carrier group (27.24％,P=0.0004).The frequency of Tim3+/PD-1+ HBV-specific CD8+ T cells was positively correlated with alanine aminotransferase (r=0.26,P=0.022),aspartate aminotransferase (r=0.28,P=0.012) and total bilirubin levels (r=0.36,P=0.001); and inversely correlated with albumin level (r=-0.35,P=0.002) in serum.Furthermore,it was positively correlated with international normalized ratio (INR,r=0.34,P =0.045) and model for end-stage liver disease score (r=0.43,P=0.027) in ACLF group.Conclusions Co-expressions of Tim-3 and PD-1 on PBMC and HBV-specific CD8+ T cells are significantly upregulated in patients with CHB,and correlated with liver inflammatory activities.These findings indicate that Tim-3 and PD-1 co-expression may involve in disease activity and liver failure in CHB.

Correlation of TLR1-10 Expression in Peripheral Blood Mononuclear Cells with Chronic Hepatitis B and Chronic Hepatitis B-related Liver Failure

Correlation of the expression of toll-like receptors in monocyte-derived dendritic cells with prognosis of chronic severe hepatitis B.

Correlation of circulating TLR2/4 expression with CD3+/4 +/8+ T cells and treg cells in HBV-related liver cirrhosis

Toll-like Receptor 7 and 9 Expression in Peripheral Blood Mononuclear Cells from Patients with Chronic Hepatitis B and Related Hepatocellular Carcinoma

Expression Profiles and Function of Toll-Like Receptors 2 and 4 in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B Patients

Expression of Toll-like receptors in peripheral blood mononuclear cells and serum inflammatory cytokine in patients with liver failure

Phenotypes and clinical significance of circulating CD4 + CD25 + regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF)

Impaired TLR3/IFN-beta Signaling in Monocyte-Derived Dendritic Cells from Patients with Acute-on-chronic Hepatitis B Liver Failure: Relevance to the Severity of Liver Damage.

Changes of the peripheral Thelper cell cytokines of patients with chronic hepatitis B during antiviral treatment

Upregulation of Toll-Like Receptor 4 on T Cells in PBMCs is Associated with Disease Aggravation of HBV-related Acute-on-chronic Liver Failure.

Correlation Between Th17 and Ntreg Cell Frequencies and the Stages of Progression in Chronic Hepatitis B

Frequency of Th17 and Treg in HBV-related acute-on-chronic liver failure and its clinical value

Relationship Between Expression of Toll-Like Receptors 2/4 in Dendritic Cells and Chronic Hepatitis B Virus Infection.

The Frequency and Skewed T-Cell Receptor Beta-Chain Variable Patterns of Peripheral Cd4(+)Cd25(+) Regulatory T-Cells Are Associated with Hepatitis B E Antigen Seroconversion of Chronic Hepatitis B Patients During Antiviral Treatment

Expression of Toll-like receptor 2,4 in peripheral Mood mononuclear cells from patients with hepatitis B virus related cirrhosis

Correlation between programmed death-1 and T-cell immunoglobulin mucin-3 co-expression on hepatitis B virus-specific CD8+ T cells and liver inflammatory activities in patients with chronic hepatitis B virus infection

Study on several immune molecules expressed on peripheral blood mononuclear cells which may play an important role in the aggravation of chronic hepatitis B

Association Between TRAIL Expression on Peripheral Blood Lymphocytes and Liver Damage in Chronic Hepatitis B

Changes and effects of helper T cells and their effector molecules on disease aggravation in patients with chronic hepatitis B

Expression of Cytokines in Monocyte-Derived Dendritic Cells after Toll Like Receptor 3 Being Triggered in Patients with Hepatitis B Related Acute-on-chronic Liver Failure

Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C.